liver biopsy

liver biopsy is a medical procedure in which a small sample of liver tissue is removed for histological examination. It is considered the gold standard (test) for diagnosing and staging many hepatological conditions, providing critical information that non-invasive tests cannot. The procedure is typically performed by a hepatologist or an interventional radiologist in a hospital setting, often guided by ultrasonography or computed tomography.

Indications and contraindications

Common indications for the procedure include the evaluation of unexplained jaundice, hepatomegaly, or abnormal liver function tests. It is crucial for diagnosing specific liver disease such as hepatitis C, hepatitis B, autoimmune hepatitis, and primary biliary cholangitis. The American Association for the Study of Liver Diseases provides guidelines for its use in assessing fibrosis and cirrhosis, particularly in the context of non-alcoholic fatty liver disease. Major contraindications include severe coagulopathy, significant ascites, and suspected hemangioma, as these conditions substantially increase procedural risk. Patient factors such as obesity or an uncooperative demeanor may also preclude a safe biopsy, necessitating alternative diagnostic strategies.

Procedure and techniques

The most common approach is the percutaneous liver biopsy, often performed using the Menghini technique or the Tru-Cut needle. The patient is typically positioned supine, and the skin over the right upper quadrant is cleansed and anesthetized with lidocaine. Real-time imaging guidance with ultrasonography is standard to avoid vital structures like the gallbladder or lung. Other techniques include the transjugular liver biopsy, where access is gained via the jugular vein and inferior vena cava, which is preferred for patients with coagulopathy. The laparoscopic liver biopsy is another option, often utilized during abdominal surgery for direct visualization and hemostasis. Samples are immediately placed in formalin for fixation and sent to pathology for processing.

Interpretation of results

The tissue sample is examined by a pathologist using various histological stains, including hematoxylin and eosin, Masson's trichrome for collagen, and special stains for iron or copper. Key findings include the degree of inflammation, necrosis, and fibrosis, which are often graded and staged using standardized systems like the METAVIR score for hepatitis C or the Batts–Ludwig system. The presence of steatosis is quantified, and features of specific disorders, such as the rosette formation in autoimmune hepatitis or the granuloma in primary biliary cholangitis, are identified. The final pathology report integrates these findings to provide a definitive diagnosis and guide treatment decisions by the hepatology team.

Risks and complications

While generally safe, the procedure carries several potential risks. The most common complication is pain at the biopsy site, often managed with analgesics like acetaminophen. More serious but rare complications include significant hemorrhage, which may require blood transfusion or intervention by interventional radiology. Bile peritonitis can occur from puncture of the biliary tree, and inadvertent puncture of adjacent organs like the colon, kidney, or lung can lead to pneumothorax or infection. The overall mortality rate is very low, but factors such as the experience of the National Institutes of Health-funded operator and the use of image guidance significantly influence complication rates. Post-procedure monitoring in a recovery room is standard.

Alternatives to liver biopsy

Due to its invasive nature, several non-invasive alternatives have been developed. Transient elastography, such as with the FibroScan device, measures liver stiffness as a surrogate for fibrosis. Serum biomarker panels like the FIB-4 index or the Enhanced Liver Fibrosis test combine routine blood tests, including aspartate transaminase and platelet count. Advanced magnetic resonance imaging techniques, including MR elastography, provide detailed anatomical and functional assessment. While these alternatives, endorsed by the European Association for the Study of the Liver, are useful for screening and monitoring, they cannot fully replace the histological detail provided for definitive diagnosis of many complex liver disease.

Category:Medical procedures Category:Hepatology Category:Pathology